您的购物车当前为空
别名 BIM-51077C, [Aib8,35]hGLP-1(7-36)NH2
Taspoglutide是一种GLP-1受体激动剂(Taspoglutide, Ki = 1.1 nM for the human receptor),在表达该受体的CHO-K1细胞中可以诱导cAMP积累(EC50 = 0.06 nM)。在进行口服葡萄糖耐量测试的Zucker糖尿病肥胖大鼠中,每周给予Taspoglutide 1 mg/动物,结果显示其能有效降低血糖和提高胰岛素水平。此外,在相同的动物模型中,Taspoglutide还能降低胃抑制肽(GIP)和甘油三酯的血浆水平,同时减轻体重。

Taspoglutide是一种GLP-1受体激动剂(Taspoglutide, Ki = 1.1 nM for the human receptor),在表达该受体的CHO-K1细胞中可以诱导cAMP积累(EC50 = 0.06 nM)。在进行口服葡萄糖耐量测试的Zucker糖尿病肥胖大鼠中,每周给予Taspoglutide 1 mg/动物,结果显示其能有效降低血糖和提高胰岛素水平。此外,在相同的动物模型中,Taspoglutide还能降低胃抑制肽(GIP)和甘油三酯的血浆水平,同时减轻体重。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
Taspoglutide acetate 相关产品
| 产品描述 | Taspoglutide, acting as an agonist for the glucagon-like peptide-1 receptor (GLP-1R; Ki = 1.1 nM for the human receptor), induces cAMP accumulation in CHO-K1 cells expressing human GLP-1R (EC50 = 0.06 nM). In oral glucose tolerance tests conducted on Zucker diabetic fatty rats, Taspoglutide (administered weekly at 1 mg/animal) significantly reduced blood glucose levels and increased insulin levels. Additionally, in the same model, it also lowered blood levels of gastric inhibitory polypeptide (GIP), plasma triglycerides, and body weight. |
| 别名 | BIM-51077C, [Aib8,35]hGLP-1(7-36)NH2 |
| 分子量 | 3339.76(Free base) |
| 分子式 | C152H232N40O45 xC2H4O2 |
| CAS No. | 1022150-16-8 |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容